Teresa Petrella is a Medical Oncologist at the Sunnybrook Odette Cancer Centre in Toronto, Canada and a Professor of Medicine at the University of Toronto. Dr. Petrella has a BSc in Molecular Biology from the University of Western Ontario and completed her MD from Queen’s University. Her Internal Medicine and Medical Oncology training was at McMaster University. She subsequently completed a fellowship in Melanoma and Breast cancer at the Sunnybrook Odette Cancer Centre along with a Masters in Health Research Methodology at McMaster University. Dr. Petrella joined the staff at OCC in 2002 and became the Head of the Melanoma Site Group. She is also the Chair of the Provincial Guidelines Melanoma Disease Site Group, Program in Evidence Based Care, that sets standards and guidelines for the diagnosis and treatment of melanoma and skin cancer in the province. She is currently the Director of the Clinical Trials Program at the Sunnybrook Odette Cancer Centre and she Co-Chairs the Canadian Melanoma Conference.

A key focus of Dr. Petrella’s research is investigating novel immunotherapies and targeted therapies for the treatment of metastatic melanoma. She is actively involved in the design and implementation of clinical trials for melanoma and non-melanoma skin cancers.